Isothermal Nucleic Acid Amplification Technology (INAAT)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Reach $6 Billion by 2030
The global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$3 Billion in the year 2023, is expected to reach US$6 Billion by 2030, growing at a CAGR of 10.3% over the period 2023-2030. INAAT Reagents, one of the segments analyzed in the report, is expected to record 10.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the INAAT Instruments segment is estimated at 10.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $898.3 Million, While China is Forecast to Grow at 9.7% CAGR
The Isothermal Nucleic Acid Amplification Technology (INAAT) market in the U.S. is estimated at US$898.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.2% and 8.6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 8% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 12 Featured) -
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies (Hangzhou) Ltd.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Witness Healthy Growth, Driven by Low-cost Advantages
Isothermal Nucleic Acid Amplification Technology (INAAT) - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of HIV, Hepatitis, and Other Infectious Disease - A Key Factor Propelling the Need for INAAT
Global Incidence of HIV by Region: 2017
Rising Global Incidence of Cancer Drives the INAAT Market
Development of New Technologies to Propel Market Expansion
Microfluidic Lab-on-a-chip Technology Aids in Expanding NAAT Use to POCT
Global Hepatitis B Incidence and Mortality Rates
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Blood Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 14: World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Central & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Central & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Central & Reference Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Active Players in United States
TABLE 32: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 41: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Active Players in Japan
TABLE 50: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Active Players in China
TABLE 59: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 65: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 68: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
Active Players in France
TABLE 80: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 83: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 86: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Active Players in Germany
TABLE 89: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 92: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 95: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 98: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 101: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 104: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Active Players in United Kingdom
TABLE 107: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 110: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 113: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 134: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
TABLE 137: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
TABLE 140: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings